Study of Panitumumab in the Treatment of Carcinoid Syndrome
Condition(s):Carcinoid SyndromeLast Updated:July 26, 2013Withdrawn
Hide Studies Not Open or Pending
Condition(s):Carcinoid SyndromeLast Updated:July 26, 2013Withdrawn
Condition(s):Carcinoid SyndromeLast Updated:October 14, 2022Completed
Condition(s):Carcinoid SyndromeLast Updated:September 20, 2013Terminated
Condition(s):Carcinoid SyndromeLast Updated:June 15, 2012Completed
Condition(s):Neuroendocrine Tumors; Carcinoid Tumor of GI System; Diarrhea; Carcinoid SyndromeLast Updated:November 3, 2022Completed
Condition(s):Carcinoid SyndromeLast Updated:March 15, 2019Completed
Condition(s):Malignant Carcinoid SyndromeLast Updated:April 30, 2020Terminated
Condition(s):Advanced Neuroendocrine Neoplasm; Carcinoid SyndromeLast Updated:September 29, 2021Withdrawn
Condition(s):Carcinoid SyndromeLast Updated:December 26, 2018Completed
Condition(s):Carcinoid SyndromeLast Updated:November 20, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.